Summary from the site of the Senate:
URSO, Deputy Minister of Economic Development . The Ministry of Economic Development following the developments of the research center in Nerviano Medical Sciences in the activities of the permanent table for the pharmaceutical industry. From information gathered, it appears that in May 2009 has been completed the process of recapitalization of the research center; process in which the Lombardy Region commitments being fulfilled in order to promote the strategic development of the science center. Among the points of the recovery plan, there is the birth of a university center that would guarantee a stable partnership with the region and boost employment, the continuation of negotiations with Pfizer, the activation of new collaborations and the possibility of a regional funding for three years. At present, as announced by the Ministry of Labour, is not received any application for redundancy payments for staff of the facility. The Ministry of Economic Development is fully available each support may be necessary for the best definition of the interventions of the new business plan, as well as to convene a round table with all interested parties.
GARAVAGLIA Massimo (LNP) . Are you satisfied that the Ministry has activated its offices to monitor the situation of Nerviano Medical Sciences, the largest research center exists in Italy and one of the best in Europe. Take action to address the critical situation of enormous economic difficulties the school is a concrete action in support of research in Italy, however, unless there should be a priority compared to "invest 300 million euro in the construction of a new research institute in Sicily. Since research is a national asset, hopes that the funding provided by the Lombardy Region will add a more active and concrete support from the state.
Roila (PD) . Is dissatisfied with the response given by the Deputy Minister, received a year's delay from the date of submission of the question, and response in place by the Government once buffered the financial emergency in 2009. Indeed, no steps to implement security research center, both financially and on the industrial side, with the search for new partnerships. Failure to renegotiate the agreement with Pfizer is bringing a level of unsustainable costs for the center and the company owner did not claim any capital injected: To prevent a short dramatic happen again a problem of financial stability and to safeguard the employment levels of the research, it is therefore imperative that the government take action to identify strategies to help ensure the continuation of research activities.
Read the original site of the Senate
